4//SEC Filing
GRAY WILLIAM GARRETT 4
Accession 0001104659-23-028602
CIK 0001651407other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:00 PM ET
Size
9.7 KB
Accession
0001104659-23-028602
Insider Transaction Report
Form 4
GRAY WILLIAM GARRETT
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-03-02$5.00/sh−3,591$17,955→ 51,374 total - Sale
Common Stock
2023-02-27$4.66/sh−1,914$8,919→ 47,465 total - Award
Common Stock
2023-02-27+7,500→ 54,965 total
Footnotes (6)
- [F1]In connection with the vesting of 3,925 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.65 to $4.69. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes shares of restricted common stock, which vest over various time periods.
- [F4]Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on February 27, 2023.
- [F5]In connection with the vesting of 7,500 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F6]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $5.00 to $5.025. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001692961
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:00 PM ET
- Size
- 9.7 KB